Lucy Dagher

2.0k total citations
31 papers, 1.3k citations indexed

About

Lucy Dagher is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Lucy Dagher has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 22 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Lucy Dagher's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Lucy Dagher is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Lucy Dagher collaborates with scholars based in Mexico, United States and Japan. Lucy Dagher's co-authors include Riccardo Lencioni, Alan P. Venook, Xiao‐Ping Chen, Laura Ladrón de Guevara, Tadatoshi Takayama, Junji Furuse, Masatoshi Kudo, Keiko Nakajima, Christos N. Papandreou and Seung Kew Yoon and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Radiology.

In The Last Decade

Lucy Dagher

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucy Dagher Mexico 15 1.2k 677 287 269 170 31 1.3k
Catherine Frenette United States 25 1.2k 1.1× 917 1.4× 166 0.6× 389 1.4× 185 1.1× 87 1.8k
Ana Matilla Spain 21 1.4k 1.2× 902 1.3× 224 0.8× 475 1.8× 118 0.7× 52 1.7k
Paolo De Paolis Italy 12 523 0.5× 1.1k 1.6× 182 0.6× 455 1.7× 58 0.3× 53 1.6k
Hidetoshi Itasaka Japan 18 731 0.6× 355 0.5× 79 0.3× 515 1.9× 109 0.6× 44 1.0k
Chao‐Hung Hung Taiwan 25 1.9k 1.6× 1.6k 2.4× 111 0.4× 267 1.0× 242 1.4× 145 2.3k
Shintaro Takaki Japan 20 954 0.8× 601 0.9× 120 0.4× 352 1.3× 86 0.5× 77 1.2k
Patricia López Switzerland 19 851 0.7× 672 1.0× 87 0.3× 637 2.4× 75 0.4× 42 1.6k
Maria Hoppe‐Lotichius Germany 23 1.0k 0.9× 536 0.8× 90 0.3× 941 3.5× 123 0.7× 64 1.8k
Yonggang Wei China 22 885 0.8× 358 0.5× 67 0.2× 796 3.0× 171 1.0× 107 1.5k
Kaori Kuramitsu Japan 13 518 0.4× 342 0.5× 62 0.2× 317 1.2× 72 0.4× 65 850

Countries citing papers authored by Lucy Dagher

Since Specialization
Citations

This map shows the geographic impact of Lucy Dagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Dagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Dagher more than expected).

Fields of papers citing papers by Lucy Dagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Dagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Dagher. The network helps show where Lucy Dagher may publish in the future.

Co-authorship network of co-authors of Lucy Dagher

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Dagher. A scholar is included among the top collaborators of Lucy Dagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Dagher. Lucy Dagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bessone, Fernando, Nelia Hernández, Martín Tagle, et al.. (2021). Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver. Annals of Hepatology. 24. 100321–100321. 34 indexed citations
3.
Marrero, Jorge A., Masatoshi Kudo, Alan P. Venook, et al.. (2016). Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study. Journal of Hepatology. 65(6). 1140–1147. 264 indexed citations
4.
Kudo, Masatoshi, Riccardo Lencioni, Jorge A. Marrero, et al.. (2016). Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study. Liver International. 36(8). 1196–1205. 36 indexed citations
5.
Geschwind, Jean-François H., Masatoshi Kudo, Jorge A. Marrero, et al.. (2016). TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. Radiology. 279(2). 630–640. 94 indexed citations
6.
Loureiro, Carmen L., et al.. (2016). Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.. PubMed. 57(1). 38–46. 5 indexed citations
7.
Méndez‐Sánchez, Nahúm, Ezequiel Ridruejo, Ângelo Alves de Mattos, et al.. (2014). Latin American Association for the Study of the Liver (LAASL) Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Annals of Hepatology. 13. S4–S40. 36 indexed citations
8.
Lencioni, Riccardo, Masatoshi Kudo, J.-P. Bronowicki, et al.. (2012). First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study. International Journal of Clinical Practice. 66(7). 675–683. 88 indexed citations
9.
Lencioni, Riccardo, Xiao‐Ping Chen, Lucy Dagher, & Alan P. Venook. (2010). Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?. The Oncologist. 15(S4). 42–52. 128 indexed citations
10.
Dagher, Lucy, et al.. (2008). ación del child-pugh y sodio sérico en pacientes con diagnóstico de cirrosis hepática en el servicio de gastroenterología Dr. Alí Rivas. Hospital Jesús Yerena, Lídice: Años 2002-2006. 62(3). 195–198.
11.
Fernández‐Mestre, Mercedes, et al.. (2007). Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver International. 27(10). 1409–1416. 43 indexed citations
12.
Dagher, Lucy. (2006). Module lXTreatment of chronic hepatitis C infection in cirrhotic patients. Annals of Hepatology. 5. 36–39. 1 indexed citations
13.
Dagher, Lucy. (2006). Treatment of chronic hepatitis C infection in cirrhotic patients. Annals of Hepatology. 5. S36–S39. 1 indexed citations
14.
Raimondo, Maria Luisa, Lucy Dagher, George Papatheodoridis, et al.. (2003). Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation. 75(2). 186–190. 62 indexed citations
15.
Dagher, Lucy & A.K. Burroughs. (2001). Variceal bleeding and portal hypertensive gastropathy. European Journal of Gastroenterology & Hepatology. 13(1). 81–88. 18 indexed citations
16.
Dagher, Lucy, et al.. (2001). The hepatorenal syndrome. Gut. 49(5). 729–737. 72 indexed citations
17.
Dagher, Lucy, David Patch, & Andrew K. Burroughs. (2000). Management of oesophageal varices. Hospital Medicine. 61(10). 711–717. 1 indexed citations
18.
Dagher, Lucy, David Patch, & Andrew K. Burroughs. (2000). Drug treatment for bleeding oesophageal varices. Best Practice & Research Clinical Gastroenterology. 14(3). 365–390. 4 indexed citations
19.
Dagher, Lucy, et al.. (1999). Influence of positive crossmatch in the outcome of liver transplantation. Transplantation Proceedings. 31(6). 2363–2363. 4 indexed citations
20.
Minelli, Lorivaldo, et al.. (1982). [Statistics on basocellular carcinoma in Londrina, Paraná, Brazil].. PubMed. 93(1). 10–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Frenette Breakdown of academic impact, for papers by Ana Matilla Breakdown of academic impact, for papers by Paolo De Paolis Breakdown of academic impact, for papers by Hidetoshi Itasaka Breakdown of academic impact, for papers by Chao‐Hung Hung Breakdown of academic impact, for papers by Shintaro Takaki Breakdown of academic impact, for papers by Patricia López Breakdown of academic impact, for papers by Maria Hoppe‐Lotichius Breakdown of academic impact, for papers by Yonggang Wei Breakdown of academic impact, for papers by Kaori Kuramitsu
Rankless by CCL
2026